Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00041600 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Human Epilepsy Genetics--Neuronal Migration Disorders Study

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoint revised
    • Eligibility criteria expanded, about 2 words
    • Study description shortened, about 4 words
    v18
  2. Primary and study completion dates: Jun 2025 to Jun 2030
    • Site contact updated
    v17
  3. Primary and study completion dates: Feb 2019 to Jun 2025
    • Study sites: 2 to 1
    • Study description shortened, about 1 word
    v16
  4. Primary completion date: Feb 2019
    • Study completion date: Feb 2014 to Feb 2019
    • Collaborators: 1 to 2
    v15
  5. Re-verified, no change to tracked fieldsv14
Show 12 earlier versionsHide 12 earlier versions
  1. Eligibility criteria expanded, about 10 words
    • Study sites revised (2)
    v13
  2. Lead sponsor: Harvard Institutes of Medicine to Harvard University Faculty of Medicinev12
  3. Study completion date: Feb 2009 to Feb 2014v11
  4. Study sites: 1 to 2
    • Study description shortened, about 22 words
    v10
  5. Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS) to Harvard Institutes of Medicine
    • Collaborators expanded, about 8 words
    v9
  6. Re-verified, no change to tracked fieldsv8
  7. Study completion date: Feb 2009v7
  8. Site contact updatedv6
  9. Site contact updatedv5
  10. Start date: Apr 1996
    • Study description expanded, about 23 words
    • Eligibility criteria shortened, about 2 words
    v4
  11. 2 versions Re-verified since Oct 12, 2005, no change to tracked fieldsv2-v3
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to identify genes responsible for epilepsy, brain malformations and disorders of human cognition.
Trial Details
NCT Number NCT00041600
Lead Sponsor Harvard University Faculty of Medicine
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS), Howard Hughes Medical Institute
Conditions
(from sponsor)		 Brain Malformation, Neuronal Migration Disorder, Cognition Disorder, Epilepsy
Related terms Choristoma, Cognition Disorders, Epilepsy, Lissencephaly, Malformations of Cortical Development, Group II, Microcephaly, Polymicrogyria, Schizencephaly, Seizures
Enrollment 3,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov